+36.1%
MRNA vs PSLV
+165.9%
-129.8%
-86.6%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 3y.
| Period | Portfolio | PSLV | Excess | Alpha |
|---|---|---|---|---|
| 1D | +5.4% | +0.3% | +5.1% | +5.3% |
| 7D | -1.1% | -3.5% | +2.4% | +0.1% |
| 30D | +126.1% | -2.1% | +128.3% | +127.7% |
| 3M | +190.0% | -1.6% | +191.7% | +190.5% |
| 6M | +157.2% | -25.5% | +182.7% | +173.9% |
| YTD | +388.2% | -11.4% | +399.6% | +387.3% |
| 1Y | +467.0% | +48.6% | +418.5% | +398.2% |
| 3Y | +36.1% | +166.9% | -130.8% | +9.2% |
| All | +36.1% | +165.9% | -129.8% | +9.2% |
Cumulative growth
Daily Returns
Daily percentage return beside PSLV.
Daily Out/Under-Performance
Portfolio return minus PSLV return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × PSLV return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 3y: compounded portfolio wealth divided by compounded PSLV wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
3y analysis · Full analysis span regression · 6 months rolling